NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 286 filers reported holding NEOGENOMICS INC in Q4 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $466,271 | +29.8% | 33,581 | +47.0% | 0.00% | – |
| Q1 2024 | $359,153 | +94.6% | 22,849 | +100.7% | 0.00% | – |
| Q4 2023 | $184,535 | +34.6% | 11,386 | +2.1% | 0.00% | – |
| Q3 2023 | $137,066 | -22.4% | 11,153 | +1.6% | 0.00% | – |
| Q2 2023 | $176,677 | -54.6% | 10,982 | -74.2% | 0.00% | – |
| Q4 2022 | $389,318 | +85.4% | 42,569 | +78.6% | 0.00% | – |
| Q3 2022 | $210,000 | -53.0% | 23,831 | -32.9% | 0.00% | -100.0% |
| Q1 2022 | $447,000 | -62.8% | 35,506 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $1,200,000 | +97.0% | 34,762 | +207.9% | 0.00% | 0.0% |
| Q4 2020 | $609,000 | +190.0% | 11,290 | +101.4% | 0.00% | – |
| Q3 2020 | $210,000 | -67.3% | 5,607 | -72.9% | 0.00% | -100.0% |
| Q2 2020 | $642,000 | +121.4% | 20,724 | +108.7% | 0.00% | 0.0% |
| Q4 2019 | $290,000 | +48.7% | 9,931 | -2.4% | 0.00% | – |
| Q3 2019 | $195,000 | – | 10,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 2,683,090 | $11,188,000 | 6.34% |
| GROW Partners, LLC | 1,140,300 | $4,755,000 | 4.35% |
| KOPP INVESTMENT ADVISORS LLC | 1,592,832 | $6,642,000 | 3.19% |
| PERKINS CAPITAL MANAGEMENT INC | 816,680 | $3,406,000 | 2.92% |
| 1492 Capital Management LLC | 786,495 | $3,280,000 | 2.05% |
| Curi RMB Capital, LLC | 4,177,053 | $17,418,000 | 1.06% |
| BARD ASSOCIATES INC | 491,100 | $2,048,000 | 0.96% |
| FALCON POINT CAPITAL, LLC | 162,475 | $678,000 | 0.62% |
| THB ASSET MANAGEMENT | 2,214,203 | $9,233,000 | 0.61% |
| NORTHPOINTE CAPITAL LLC | 1,033,821 | $4,311,000 | 0.52% |